A detailed history of Thoroughbred Financial Services, LLC transactions in Novartis Ag stock. As of the latest transaction made, Thoroughbred Financial Services, LLC holds 3,990 shares of NVS stock, worth $392,416. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,990
Previous 4,719 15.45%
Holding current value
$392,416
Previous $502,000 8.76%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$106.13 - $120.89 $77,368 - $88,128
-729 Reduced 15.45%
3,990 $458,000
Q2 2024

Aug 08, 2024

BUY
$92.57 - $107.37 $188,657 - $218,820
2,038 Added 76.02%
4,719 $502,000
Q1 2024

May 07, 2024

SELL
$95.27 - $108.47 $161,482 - $183,856
-1,695 Reduced 38.73%
2,681 $259,000
Q4 2023

Feb 09, 2024

SELL
$92.27 - $101.54 $48,072 - $52,902
-521 Reduced 10.64%
4,376 $441,000
Q3 2023

Nov 08, 2023

BUY
$94.73 - $105.13 $171,366 - $190,180
1,809 Added 58.58%
4,897 $498,000
Q2 2023

Aug 03, 2023

SELL
$92.52 - $104.91 $1,110 - $1,258
-12 Reduced 0.39%
3,088 $311,000
Q1 2023

Apr 24, 2023

BUY
$80.03 - $92.81 $1,360 - $1,577
17 Added 0.55%
3,100 $285,000
Q1 2022

May 04, 2022

BUY
$80.11 - $90.62 $246,979 - $279,381
3,083 New
3,083 $270,000
Q2 2020

Jul 20, 2020

SELL
$80.93 - $91.1 $248,212 - $279,403
-3,067 Closed
0 $0
Q1 2020

Apr 23, 2020

BUY
$70.67 - $99.01 $1,060 - $1,485
15 Added 0.49%
3,067 $253,000
Q2 2019

Jul 16, 2019

SELL
$75.4 - $92.8 $20.8 Million - $25.6 Million
-275,626 Reduced 98.9%
3,052 $0
Q2 2019

Jul 16, 2019

BUY
$75.4 - $92.8 $20.8 Million - $25.6 Million
275,626 Added 9031.0%
278,678 $0
Q1 2019

May 07, 2019

SELL
$75.32 - $86.15 $9,866 - $11,285
-131 Reduced 4.12%
3,052 $293,000
Q4 2018

Feb 13, 2019

BUY
$73.66 - $82.02 $234,459 - $261,069
3,183 New
3,183 $273,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Thoroughbred Financial Services, LLC Portfolio

Follow Thoroughbred Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thoroughbred Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thoroughbred Financial Services, LLC with notifications on news.